Cannabis Law Report

JUNE 25, 2021

Ontario Cannabis Retail Corporation Act, 2017. Use of Non-controlled Cannabinoids in Food. The federal Cannabis Act and the regulations enacted thereunder contain extensive provisions relating to how cannabinoids can be incorporated into food and other products. Ontario Regulation 268/18. Prince Edward Island.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

TheAnswerPage

FEBRUARY 25, 2022

Despite its cultivation as a source of food, fiber and medicine, and its global status as the most frequently used illicit drug, plants in the genus Cannabis currently experience an inconclusive taxonomic organization and evolutionary history. UF/IFAS Master Gardener (Miami-Dade County). Cannabis sativa – One plant, Many crops.

Sativa 40

Sativa Hybrid Terpenes Indica 40

CannaMD

NOVEMBER 6, 2019

Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. Some of the more interesting data on the relationship between opioids and medical marijuana for pain management comes from the field of orthopedic surgery. million to 11.4 Study author, Thomas R.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Healer

MARCH 26, 2021

THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant. Seventeen of 19 pre-clinical studies provided “robust” evidence of the opioid-sparing effects of cannabinoids, but one of the nine clinical studies provided “very low-quality” evidence of such, according to the review.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] 2017), [link] ; see also 21 U.S.C. § 811(b)–(c). [18]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as medicine against HIV. What is HIV and how is it manifested? 2016 ( 3 ). University of Florida received a 3.2

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. A need for data at all of these levels and data specific to product type drives more advanced methodology in the laboratories, often resulting in a better understanding of the matrix and more accurate data.

Business 95

Business Data Wellness and Beauty Safety 95

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. “The Something needs to be done”: Making medicine attainable and affordable.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Cannabis Law Report

JUNE 11, 2019

This report provides an analysis of the latest data on the drug situation and responses to it across the European Union, Norway and Turkey. It is supported by other, online information resources, including our Statistical Bulletin, containing source data. This is a complex area. This is a complex area.

Medicine 40

Medicine Data THC Policy 40

The Joint Blog

NOVEMBER 8, 2019

” As noted by NORML, separate survey data published in January in the journal BMC Complementary and Alternative Medicine reported that the use of cannabis was the most effective self-management strategy engaged in by endometriosis patients.

Patients 42

Patients CBD Environment History 42

Cannabis Law Report

NOVEMBER 29, 2019

More than 100 of them are cannabinoids. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. When cannabinoids enter the human body, they start interacting with the endocannabinoid system which is the network of cell receptors throughout the brain and body. In the U.S.,

Research and Development 59

Research and Development THC Cannabinoids CBD 59

Cannabis Law Report

JANUARY 27, 2020

In Europe, probably more than in any other part of the world, safety is taken incredibly seriously – and has often been used time and time again to banish non-medicinal products and supplements from the market, irrespective of the benefits they might provide to citizens. Inevitably, this is an area we’re watching very closely.

Safety 59

Safety CBD Food Seed-To-Sale 59

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. million more on CBD products in 2021 compared to 2017 — a 413.4%

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

DECEMBER 8, 2019

Editor’s note: The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. On the one hand, cannabinoids produced by cannabis clearly have medicinal benefits.3-5

Medicine 59

Medicine Research and Development Food Cannabinoids 59

CannaMD

SEPTEMBER 15, 2020

Where can you use your medicine and when are you at risk of getting arrested? A special legislative session in June 2017 passed Senate Bill 8A , the Medical Use of Marijuana Act , to implement rules for making medical marijuana available to Floridians. Regular cannabis is not subject to cannabinoid limits and/or ratios.

Law 126

Law Marijuana Patients Treatment 126

The Cannigma

MARCH 29, 2021

The major active chemicals in cannabis — cannabinoids — are able to trigger receptors that control the endocannabinoid system, modifying the function of those receptors and the connected systems, including the cardiovascular system. “The Why cannabis makes your heart race. Shutterstock.

Blood Pressure 143

Blood Pressure Indica THC Strains 143

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52

FloridaMarijuana.net

AUGUST 13, 2018

In 2017, The Center for Disease Control and Prevention listed lack of sleep/insufficient sleep as a public health concern. Even mainstream media has profiled the medicinal effects of cannabis. A 2014 study by Hawaii Journal of Medicine and Public Health surveyed 100 users of medicinal cannabis. The mean age was 49.3

Sleep 180

Sleep Chronic Pain Marijuana Cannabinoids 180

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 98

CBD Chronic Pain Oil Topical 98

SpeedWeed

JULY 8, 2021

In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. Detwiler said. “I

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Canna Care Docs

AUGUST 21, 2019

Sununu’s analysis is disheartening for cannabis advocates who see pot as a safe alternative to prescription painkillers, his words are reflective of a larger consensus that refuses to accept the medicinal value of cannabis by instead relegating it to the insidious and stigmatized category of “drugs.”. According to the U.S.

Chronic Pain 40

Chronic Pain Medicine Programs Patients 40

SpeedWeed

JULY 8, 2021

In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. Detwiler said. “I

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. Detwiler said. “I

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. Detwiler said. “I

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Supply Chain 52

SpeedWeed

JULY 6, 2021

In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. Detwiler said. “I

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

However, if you have not experienced the power of CBDA (and most people haven’t because CBDA is not included in most products that are manufactured with heat), this guide will explain what we are now learning about this powerful minor cannabinoid and how it can work together with CBD or in place of CBD to address and prevent symptoms.

CBD 52

CBD Chronic Pain Oil Topical 52

Cannabis Law Report

JUNE 2, 2022

Cannabis contains more than 421 different chemical compounds, including a group of more than 60 bioactive compounds (called cannabinoids). Cannabinoids in raw (unprocessed) cannabis plants include tetrahydrocannabinolic acid (THCA), which, with heat, time, and/or light transforms into THC, the main psychoactive compound of cannabis products.

THC 52

THC Concentrates History Cannabis 52

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. government-held patent on “Cannabinoids as antioxidants and neuroprotectants.”. Cannabinoids to the rescue. But the U.S. BY MARTIN A.

THC 64

THC CBD Cannabinoids Research and Development 64

CannaTech

JULY 19, 2018

In simple terms, the WHO is revisiting their stance on the safety and efficacy of cannabis as medicine; good news for countless legal, medical, and academic reasons. The critical review on CBD follows a November 2017 pre-review that concluded there is not enough evidence to justify the scheduling of CBD.

CBD 73

CBD Research and Development THC Patients 73

Otherside Farms

DECEMBER 10, 2019

What scientists do recognize is that cannabinoids act with the endocannabinoid receptors situated within the body. According to experts, CBD is used due to its healing properties, though there’s no conclusive data on this use. What Dog Health issues will CBD Oil Treat? Possible Side Effects of CBD in Dogs.

Oil 18

Oil CBD Pets Blood Pressure 18

Weedistry

MARCH 8, 2019

Cannabis oil – which, when produced for medical purposes, contains carefully controlled amounts of the cannabinoids cannabidiol (CBD) and tetrahydrocannabinol (THC) – continues to be the subject of much debate. THC – between 2015 and 2017. Discover more as we explore the dynamic world of medical cannabis.

Oil 40

Oil Treatment Patients THC 40

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Data 52

Data Safety Cannabinoids Cannabis 52